Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial

Bansback, 2017, 10, 311 Bass, 2003, A shortened instrument for literacy screening, J. Gen. Intern. Med., 18, 1036, 10.1111/j.1525-1497.2003.10651.x Basso, 2010, Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit, J. Clin. Exp. Neuropsychol., 32, 1050, 10.1080/13803391003683062 Berry, 2006, Expressing medicine side effects: assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information, Patient Educ. Couns., 63, 89, 10.1016/j.pec.2005.09.003 Browne, 2014, Atlas of MS 2013: a growing global problem with widespread inequity, Neurology, 83, 1022, 10.1212/WNL.0000000000000768 Colligan, 2017, Shared decision-making in multiple sclerosis : a review, Mult. Scler. J., 23, 185, 10.1177/1352458516671204 Colombo, 2014, Web search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postings, Interact. J. Med. Res., 3, e12, 10.2196/ijmr.3034 Dwan, 2019, CONSORT 2010 statement: extension to randomised crossover trials, BMJ, 366 Garvelink, 2019, Decisional conflict scale use over 20 years: the anniversary review, Med. Decis. Mak., 39, 301, 10.1177/0272989X19851345 Gigerenzer, 2003, Simple tools for understanding risks: from innumeracy to insight, BMJ Br. Med. J., 327, 741, 10.1136/bmj.327.7417.741 Greiner, 2015, 8, 541 Hamstra, 2014, The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy, Med. Decis. Mak., 35, 27, 10.1177/0272989X14551639 Hawley, 2008, The impact of the format of graphical presentation on health-related knowledge and treatment choices, Patient Educ. Couns., 73, 448, 10.1016/j.pec.2008.07.023 Hay, 2008, Why patients go online: multiple sclerosis, the internet, and physician-patient communication, Neurologist, 14, 374, 10.1097/NRL.0b013e31817709bb Johnson, 2017, Giving patients a meaningful voice in united states regulatory decision making: the role for health preference research, Patient, 10, 523, 10.1007/s40271-017-0250-z Kasper, 2008, Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial, Eur. J. Neurol. Kasper, J., 15, 1345, 10.1111/j.1468-1331.2008.02313.x Keeney, 1958, Collated near-vision test card, Am. J. Opthalomol., 46, 592, 10.1016/0002-9394(58)91140-1 Kopke, 2016, Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded study, Clin. Rehabil. England Köpke, 2009, Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial, Mult. Scler., 15, 96, 10.1177/1352458508095921 Köpke, 2014, Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial, J. Neurol. Neurosurg. Psychiatry, 85, 411, 10.1136/jnnp-2013-306441 Krupp, 1989, The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus, Arch Neurol, 46, 1121, 10.1001/archneur.1989.00520460115022 Langdon, 2012, Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS), Mult. Scler. J., 18, 891, 10.1177/1352458511431076 Langdon, 1995 Langdon, 2011, Cognition in multiple sclerosis, Curr. Opin. Neurol., 24, 244, 10.1097/WCO.0b013e328346a43b Legare, 2012, Patients perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice, Patient, 5, 1, 10.2165/11592180-000000000-00000 Litster, 2016, Screening tools for anxiety in persons with multiple sclerosis: a systematic review, Int. J. MS Care., 1537 McCaffery, 2012, The influence of graphic display format on the interpretations of quantitative risk information among adults with lower education and literacy: a randomized experimental study, Med. Decis. Mak., 32, 532, 10.1177/0272989X11424926 Mühlbauer, 2018, Alternative package leaflets improve people's understanding of drug side effects—a randomized controlled exploratory survey, PLoS One, 13, 1, 10.1371/journal.pone.0203800 O'Connor, 1995, Validation of a decisional conflict scale, Med. Decis. Mak., 15, 25, 10.1177/0272989X9501500105 Oudhoff, 2015, The effect of different graphical and numerical likelihood formats on perception of likelihood and choice, Med. Decis. Mak., 487, 10.1177/0272989X15576487 Poirier, 2019, What eye-tracking methods can reveal about the role of information format in decision-aid processing: an exploratory study Protheroe, 2007, Effectiveness of a computerized decision aid in primary care on decision making and quality of life in menorrhagia: results of the MENTIP randomized controlled trial, Med. Decis. Make., 27, 575, 10.1177/0272989X07306785 Rae-Grant, 2018, Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis, Neurology, 90, 777, 10.1212/WNL.0000000000005347 Rahn, 2018, Nurse-led immunotreatment DEcision coaching in people with multiple sclerosis (DECIMS) – feasibility testing, pilot randomised controlled trial and mixed methods process evaluation, Int. J. Nurs. Stud., 78, 26, 10.1016/j.ijnurstu.2017.08.011 Rath, L., Vijiaratnam, N., Skibina, O. Assessing understanding: patients prescribed natalizumab for multiple sclerosis individual risk and symptoms of progressive multifocal leukoencephalopathy. 2016;194–9. Reen, 2017, Multiple sclerosis patients’ understanding and preferences for risks and benefits of disease-modifying drugs: a systematic review, J. Neurol. Sci. Elsevier B.V., 375, 107, 10.1016/j.jns.2016.12.038 Reen, 2017, Interventions to support risk and benefit understanding of disease-modifying drugs in multiple sclerosis patients: a systematic review, Patient Educ. Couns. Elsevier Ireland Ltd;, 100, 1031, 10.1016/j.pec.2016.12.028 Reen, 2017, Multiple sclerosis patients’ understanding and preferences for risks and benefits of disease-modifying drugs: a systematic review, J. Neurol. Sci., 375, 107, 10.1016/j.jns.2016.12.038 Reen, 2018, Best methods of communicating clinical trial data to improve understanding of treatments for patients with multiple sclerosis, Value Heal., 21, 762, 10.1016/j.jval.2017.12.015 Rieckmann, 2018, Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st century steering group, Mult. Scler. Relat. Disord., 19, 153, 10.1016/j.msard.2017.11.013 Rommer, 2018, Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients, Expert Opin. Pharmacother., 19, 483, 10.1080/14656566.2018.1446944 Senn, 2002 Stanca, C.O., Birgit, P., Diego, B., Giambastiani, CM. Joint healthcare professional and patient development of communication tools to improve the standard of MS care. 2019. Sumowski, 2018, Cognition in multiple sclerosis: state of the field and priorities for the future, Neurology, 90, 278, 10.1212/WNL.0000000000004977 The Academy of Medical Sciences. Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines. 2017. Thomas, 2016, The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis, J. Med. Econ., 19, 497, 10.3111/13696998.2015.1134546 Thompson, 2018, Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol, 17, 162, 10.1016/S1474-4422(17)30470-2 Trojano, 2017, Treatment decisions in multiple sclerosis — insights from real-world observational studies, Nat. Rev. Neurol., 10.1038/nrneurol.2016.188 Turner a, 2007, Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model, Mult. Scler., 13, 1146, 10.1177/1352458507078911 Wechsler, 2001 Yeandle, 2018, Patient power revolution in multiple sclerosis: navigating the new frontier, Neurol. Ther. Springer Healthcare;, 7, 179, 10.1007/s40120-018-0118-8 Zigmond a, 1983, The hospital anxiety and depression scale, Acta Psychiatry Scand., 67, 361, 10.1111/j.1600-0447.1983.tb09716.x Zipkin, 2014, Evidence-based risk communication: a systematic review, Ann. Intern Med., 161, 270, 10.7326/M14-0295